OBP, founded in 1992, is a venture capital firm focused on providing funding and managerial support to start-up companies in the life sciences and healthcare fields. Though open to investing in companies of various stages, OBP primarily works with early-stage enterprises. With over $1 billion of committed funds at their disposal, OBP has invested in more than 140 life science companies globally.
81
Total Investments
41
Portfolio Companies
-
Exits
4
Industries
General Information
Industries
Biotechnology, Financial Services +2
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Oxford Bioscience Partners
Recent Investments (81)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Jan 2017 | |
| Debt Financing | •••••• | Sep 2013 | |
| Series C | •••••• | Jul 2013 | |
| Series D | •••••• | May 2012 | |
| Debt Financing | •••••• | Jan 2012 | |
|
|
Debt Financing | •••••• | Sep 2010 |
|
|
Venture Round | •••••• | Sep 2010 |
|
|
Venture Round | •••••• | Apr 2010 |
|
|
Series D | •••••• | Mar 2010 |
|
|
Series E | •••••• | Jan 2010 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.